Abstract
The effects of new thienodiazepine derivatives, such as clotiazepam and Y-7131, on normal human sleep were investigated on 5 subjects and compared to those of benzodiazepine derivatives, such as diazepam and nitrazepam. REM sleep was significantly decreased only with 2 mg of Y-7131 and rebound elevation of REM sleep did not follow in recovery 1 and 2 nights. By using partial differential REM deprivation which was designed by us, there was also no rebound elevation of REM sleep noted in recovery 2 night following 2 mg of Y-7131 medication. REM sleep was not suppressed with 15 mg of clotiazepam, 6 mg of diazepam and 10 mg of nitrazepam when compared to the baseline night. With regard to NREM sleep, stage 2 was significantly increased with 15 mg of clotiazepam and 10 mg of nitrazepam, but stage SWS was significantly decreased with 10 mg of nitrazepam.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Dunleavy, D. L. F., Brezinova, V., Oswald, I., MacLean, A. W., Tinker, M.: Changes during weeks in effects of tricyclic drugs on the human sleeping brain. Brit. J. Psychiat. 120, 663–672 (1972)
Gastaut, H., Lob, H., Papy, J. J.: Action of mogadon on the stage of REM sleep. Electroenceph. clin. Neurophysiol. 23, 288 (1969)
Haider, I., Oswald, I.: Late brain recovery processes after drug overdose. Brit. med. J. 1970 II, 318–322
Hartmann, E.: On the pharmacology of dreaming sleep. J. nerv. ment. Dis. 146, 165–173 (1968)
Hartmann, E.: Pharmacological studies of sleep and dreaming: chemical and clinical relationship. Biol. Psychiat. 1, 243–258 (1969a)
Hartmann, E.: Antidepressants and sleep. Clinical and theoretical implications. In: Sleep, physiology and pathology, A. Kales, ed., pp. 308–316. Philadelphia: Lippincott 1969 b
Hartmann, E.: The D-state and norepinephrine-dependent systems. Int. Psychiat. Clin. 7, 308–328 (1970)
Hartmann, E., Cravens, J.: The effects of long term administration of psychotropic drugs on human sleep. Psychopharmacologia (Berl.) 33, 185–202 (1973)
Jouvet, M.: Mechanisms of the states of sleep: a neuro-pharmacological approach. Res. Publ. Ass. nerv. ment. Dis. 45, 86–126 (1967)
Kales, A., Scharfe, M., Tan, L., Kales, K., Allen, C., Malmstorm, E.: Sleep patterns with short term drug use. Psychophysiology 6, 262–263 (1969)
King, C. D.: The pharmacology of rapid eye movement sleep. Advanc. Pharmacol. Chemother. 9, 1–91 (1971)
Lewis, S. A., Oswald, I.: Overdose of tricyclic antidepressants and deductions concerning their cerebral action. Brit. J. Psychiat. 115, 1403–1410 (1969)
Lewis, S. A., Oswald, I.: Overdose of tricyclic antidepressants and REM sleep rebound. Electroenceph. clin. Neurophysiol. 28, 211–212 (1970)
Nakanishi, M., Tsumagari, T., Shuto, S., Kenjo, T., Fukuda, T., Setoguchi, M.: Pharmacological profile of 6-o-chloro-phenyl-8-ethyl-1-methyl-4H-s-triazolo (3,4-c) thieno (2, 3-e) (1,4) diazepine (Y-7131). Presented at Annual Meeting of Japanese Pharmacological Society, Tokyo, Japan (1974)
Nakanishi, M., Tsumagari, T., Takigawa, Y., Shuto, S., Kenjo, T., Fukuda, T.: Studies on psychotropic drugs. 19: Psychopharmacological studies of 1-methyl-5-o-chloro-phenyl-7-ethyl-1,2-dihydro-3H-thieno (2,3-e) (1,4) dia-zepine-2-one (Y-6047). Arzneimittel-Forsch. 22, 1905–1914 (1972)
Nakashima, K.: unpublished data.
Nakazawa, Y., Kotorii, M., Horikawa, S., Ohshima, M.: Effects of amitriptyline on human sleep as evaluated by using partial differential REM deprivation (PDRD). Electroenceph. clin. Neurophysiol. 38, 513–520 (1975a)
Nakazawa, Y., Kotorii, M., Tachibana, H., Nakano, T.: Individual differences in compensatory rebound of REM sleep, with particular reference to their relationship to personality and behavioral characteristics. J. nerv. ment. Dis. (in press 1975b)
Nakazawa, Y., Tachibana, H., Kotorii, M., Ogata, M.: Effects of l-Dopa on natural night sleep and on rebound of REM sleep. Folia psychiat. neurol. jap. 27, 223–230 (1973)
Namiki, S., Kawakami, S., Hasegawa, N., Suzuki, J., Higuchi, M., Ueno, H., Nakano, S., Tanaka, M., Imamori, K., Uemura, N., Ogawa, N.: A clinical evaluation of a new anxiolytic drug (thienodiazepine derivative, Y-6047) in neurotics and psychosomatic disorders. J. Jap. Psychosom. Soc. 13, 180–186 (1973)
Oswald, I.: Some psychophysiological features of human sleep. Progr. Brain Res. 18, 160–169 (1965)
Oswald, I.: Sleep and dependence on amphetamine and other drugs. In: Sleep, physiology and pathology, A. Kales, ed., pp. 317–330. Philadelphia: Lippincott 1969a
Oswald, I.: Human brain protein, drugs and dreams. Nature (Lond.) 23, 893–897 (1969b)
Oswald, I.: Drug research and human sleep. Ann. Rev. Pharmacol. 13, 243–252 (1973)
Oswald, I., Priest, R. G.: Five weeks to escape the sleepingpill habit. Brit. med. J. 1965 I, 1093–1095
Rechtschaffen, A., Kales, A.: A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Public Health Service, U.S. Government Printing Office, Washington D.C., pp. 1–62 (1968)
Tissot, R.: The effects of certain drugs on the sleep cycle in man. Progr. Brain Res. 18, 175–177 (1965)
Wallach, M. B., Winters, W. D., Mandell, A. J., Spooner, E.: Effects of antidepressant drugs on wakefulness and sleep in the cat. Electroenceph. clin. Neurophysiol. 27, 574–580 (1969)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nakazawa, Y., Kotorii, M., Ohshima, M. et al. Effects of thienodiazepine derivatives on human sleep as compared to those of benzodiazepine derivatives. Psychopharmacologia 44, 165–171 (1975). https://doi.org/10.1007/BF00421005
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00421005